{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:56:52Z","timestamp":1792807012996,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang provincial medicine and health discipline platform project","award":["2018RC058"],"award-info":[{"award-number":["2018RC058"]}]},{"name":"Zhejiang provincial health department platform backbone project","award":["2016147237"],"award-info":[{"award-number":["2016147237"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61602419"],"award-info":[{"award-number":["61602419"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese medicine research foundation project of Zhejiang Province","award":["2018ZA037"],"award-info":[{"award-number":["2018ZA037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The purpose of this study was to investigate the value of wavelet-transformed radiomic MRI in predicting the pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) for patients with locally advanced breast cancer (LABC).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Fifty-five female patients with LABC who underwent contrast-enhanced MRI (CE-MRI) examination prior to NAC were collected for the retrospective study. According to the pathological assessment after NAC, patient responses to NAC were categorized into pCR and non-pCR. Three groups of radiomic textures were calculated in the segmented lesions, including (1) volumetric textures, (2) peripheral textures, and (3) wavelet-transformed textures. Six models for the prediction of pCR were Model I: group (1), Model II: group (1)\u2009+\u2009(2), Model III: group (3), Model IV: group (1)\u2009+\u2009(3), Model V: group (2)\u2009+\u2009(3), and Model VI: group (1)\u2009+\u2009(2)\u2009+\u2009(3). The performance of predicting models was compared using the area under the receiver operating characteristic (ROC) curves (AUC).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The AUCs of the six models for the prediction of pCR were 0.816\u2009\u00b1\u20090.033 (Model I), 0.823\u2009\u00b1\u20090.020 (Model II), 0.888\u2009\u00b1\u20090.025 (Model III), 0.876\u2009\u00b1\u20090.015 (Model IV), 0.885\u2009\u00b1\u20090.030 (Model V), and 0.874\u2009\u00b1\u20090.019 (Model VI). The performance of four models with wavelet-transformed textures (Models III, IV, V, and VI) was significantly better than those without wavelet-transformed textures (Model I and II). In addition, the inclusion of volumetric textures or peripheral textures or both did not result in any improvements in performance.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Wavelet-transformed textures outperformed volumetric and\/or peripheral textures in the radiomic MRI prediction of pCR to NAC for patients with LABC, which can potentially serve as a surrogate biomarker for the prediction of the response of LABC to NAC.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-020-6523-2","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T14:03:48Z","timestamp":1580911428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Predicting the response to neoadjuvant chemotherapy for breast cancer: wavelet transforming radiomics in MRI"],"prefix":"10.1186","volume":"20","author":[{"given":"Jiali","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2396-1600","authenticated-orcid":false,"given":"Maosheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,5]]},"reference":[{"issue":"10074","key":"6523_CR1","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck N, Gnant M. Breast cancer. Lancet (London, England). 2017;389(10074):1134\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(16)31891-8.","journal-title":"Lancet (London, England)"},{"issue":"1","key":"6523_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21332.","journal-title":"CA Cancer J Clin"},{"key":"6523_CR3","doi-asserted-by":"publisher","unstructured":"Rivera-Rodriguez N, Cabanillas F, Lawrenson L, et al. Abstract P3-14-17: results of a novel neoadjuvant chemotherapy (NAC) for breast cancer. Cancer Res. 2013;73(24 Supplement):P3-14-17-P3-14-17). https:\/\/doi.org\/10.1158\/0008-5472.SABCS13-P3-14-17.","DOI":"10.1158\/0008-5472.SABCS13-P3-14-17"},{"issue":"3","key":"6523_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1148\/radiol.2016160176","volume":"283","author":"G Santamaria","year":"2017","unstructured":"Santamaria G, Bargallo X, Fernandez PL, Farrus B, Caparros X, Velasco M. Neoadjuvant systemic therapy in breast Cancer: Association of Contrast-enhanced MR imaging findings, diffusion-weighted imaging findings, and tumor subtype with tumor response. Radiology. 2017;283(3):663\u201372. https:\/\/doi.org\/10.1148\/radiol.2016160176.","journal-title":"Radiology."},{"issue":"15","key":"6523_CR5","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1200\/JCO.2011.41.3161","volume":"30","author":"AF Schott","year":"2012","unstructured":"Schott AF, Hayes DF. Defining the benefits of neoadjuvant chemotherapy for breast cancer. J Clin Oncol. 2012;30(15):1747\u20139. https:\/\/doi.org\/10.1200\/JCO.2011.41.3161.","journal-title":"J Clin Oncol"},{"issue":"15","key":"6523_CR6","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","volume":"30","author":"G von Minckwitz","year":"2012","unstructured":"von Minckwitz G, Untch M, Blohmer J-U, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol. 2012;30(15):1796\u2013804. https:\/\/doi.org\/10.1200\/JCO.2011.38.8595.","journal-title":"J Clin Oncol"},{"key":"6523_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12916-015-0472-7","volume":"13","author":"H Earl","year":"2015","unstructured":"Earl H, Provenzano E, Abraham J, et al. Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes - what does it all mean? BMC Med. 2015;13:234. https:\/\/doi.org\/10.1186\/s12916-015-0472-7.","journal-title":"BMC Med"},{"issue":"21","key":"6523_CR8","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1056\/NEJMoa1510764","volume":"373","author":"JA Sparano","year":"2015","unstructured":"Sparano JA, Gray RJ, Makower DF, et al. Prospective validation of a 21-gene expression assay in breast Cancer. N Engl J Med. 2015;373(21):2005\u201314. https:\/\/doi.org\/10.1056\/NEJMoa1510764.","journal-title":"N Engl J Med"},{"issue":"1","key":"6523_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.18383\/j.tom.2016.00241","volume":"3","author":"G Thibault","year":"2017","unstructured":"Thibault G, Tudorica A, Afzal A, et al. DCE-MRI Texture Features for Early Prediction of Breast Cancer Therapy Response. Tomography. 2017;3(1):23\u201332. https:\/\/doi.org\/10.18383\/j.tom.2016.00241.","journal-title":"Tomography"},{"issue":"2","key":"6523_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1148\/radiol.2017170143","volume":"286","author":"F Chamming\u2019s","year":"2018","unstructured":"Chamming\u2019s F, Ueno Y, Ferre R, et al. Features from computerized texture analysis of breast cancers at pretreatment MR imaging are associated with response to Neoadjuvant chemotherapy. Radiology. 2018;286(2):412\u201320. https:\/\/doi.org\/10.1148\/radiol.2017170143.","journal-title":"Radiology"},{"issue":"1","key":"6523_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13058-017-0846-1","volume":"19","author":"NM Braman","year":"2017","unstructured":"Braman NM, Etesami M, Prasanna P, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res. 2017;19(1):57. https:\/\/doi.org\/10.1186\/s13058-017-0846-1.","journal-title":"Breast Cancer Res"},{"key":"6523_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejrad.2017.06.019","volume":"94","author":"M Fan","year":"2017","unstructured":"Fan M, Wu G, Cheng H, Zhang J, Shao G, Li L. Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients. Eur J Radiol. 2017;94:140\u20137. https:\/\/doi.org\/10.1016\/j.ejrad.2017.06.019.","journal-title":"Eur J Radiol"},{"issue":"5","key":"6523_CR13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/jmri.25279","volume":"44","author":"J Wu","year":"2016","unstructured":"Wu J, Gong G, Cui Y, Li R. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy. J Magn Reson Imaging. 2016;44(5):1107\u201315. https:\/\/doi.org\/10.1002\/jmri.25279.","journal-title":"J Magn Reson Imaging"},{"issue":"8","key":"6523_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/nbm.3132","volume":"27","author":"JR Teruel","year":"2014","unstructured":"Teruel JR, Heldahl MG, Goa PE, et al. Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. NMR Biomed. 2014;27(8):887\u201396. https:\/\/doi.org\/10.1002\/nbm.3132.","journal-title":"NMR Biomed"},{"key":"6523_CR15","doi-asserted-by":"publisher","first-page":"103348","DOI":"10.1016\/j.compbiomed.2019.103348","volume":"112","author":"JS Majeed Alneamy","year":"2019","unstructured":"Majeed Alneamy JS, A Hameed Alnaish Z, Mohd Hashim SZ, Hamed Alnaish RA. Utilizing hybrid functional fuzzy wavelet neural networks with a teaching learning-based optimization algorithm for medical disease diagnosis. Comput Biol Med. 2019;112:103348. https:\/\/doi.org\/10.1016\/j.compbiomed.2019.103348.","journal-title":"Comput Biol Med"},{"key":"6523_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.compbiomed.2018.11.001","volume":"104","author":"DK Das","year":"2019","unstructured":"Das DK, Dutta PK. Efficient automated detection of mitotic cells from breast histological images using deep convolution neutral network with wavelet decomposed patches. Comput Biol Med. 2019;104:29\u201342. https:\/\/doi.org\/10.1016\/j.compbiomed.2018.11.001.","journal-title":"Comput Biol Med"},{"issue":"6","key":"6523_CR17","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1021\/ci034160g","volume":"43","author":"V Svetnik","year":"2003","unstructured":"Svetnik V, Liaw A, Tong C, Culberson JC, Sheridan RP, Feuston BP. Random forest: a classification and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci. 2003;43(6):1947\u201358. https:\/\/doi.org\/10.1021\/ci034160g.","journal-title":"J Chem Inf Comput Sci"},{"issue":"4","key":"6523_CR18","doi-asserted-by":"publisher","DOI":"10.2196\/15601","volume":"7","author":"QA Rahman","year":"2019","unstructured":"Rahman QA, Janmohamed T, Clarke H, Ritvo P, Heffernan J, Katz J. Interpretability and class imbalance in prediction models for pain volatility in manage my pain app users: analysis using feature selection and majority voting methods. JMIR Med Inform. 2019;7(4):e15601. https:\/\/doi.org\/10.2196\/15601.","journal-title":"JMIR Med Inform"},{"issue":"2","key":"6523_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/09553002.2020.1683638","volume":"96","author":"Ion Udroiu","year":"2019","unstructured":"Udroiu I, Sgura A. Quantitative relationships between acentric fragments and micronuclei: new models and implications for curve fitting. Int J Radiat Biol. 2019:1\u20139. https:\/\/doi.org\/10.1080\/09553002.2020.1683638.","journal-title":"International Journal of Radiation Biology"},{"issue":"1","key":"6523_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1756-0381-6-16","volume":"6","author":"M Nakamura","year":"2013","unstructured":"Nakamura M, Kajiwara Y, Otsuka A, Kimura H. LVQ-SMOTE - learning vector quantization based synthetic minority over-sampling technique for biomedical data. BioData Min. 2013;6(1):16. https:\/\/doi.org\/10.1186\/1756-0381-6-16.","journal-title":"BioData Min"},{"key":"6523_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1613\/jair.953","volume":"16","author":"N Chawla","year":"2002","unstructured":"Chawla N, Bowyer K, Hall L, Kegelmeyer W. SMOTE: synthetic minority over-sampling technique. J Artif Intell Res. 2002;16:321\u201357. https:\/\/doi.org\/10.1613\/jair.953.","journal-title":"J Artif Intell Res"},{"issue":"6","key":"6523_CR22","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1136\/amiajnl-2012-001460","volume":"20","author":"DI Golden","year":"2013","unstructured":"Golden DI, Lipson JA, Telli ML, Ford JM, Rubin DL. Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer. J Am Med Inform Assoc. 2013;20(6):1059\u201366. https:\/\/doi.org\/10.1136\/amiajnl-2012-001460.","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"6523_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.media.2013.10.005","volume":"18","author":"A Depeursinge","year":"2014","unstructured":"Depeursinge A, Foncubierta-Rodriguez A, Van De Ville D, Muller H. Three-dimensional solid texture analysis in biomedical imaging: review and opportunities. Med Image Anal. 2014;18(1):176\u201396. https:\/\/doi.org\/10.1016\/j.media.2013.10.005.","journal-title":"Med Image Anal"},{"issue":"3","key":"6523_CR24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1148\/radiol.2016160261","volume":"282","author":"J-H Kim","year":"2017","unstructured":"Kim J-H, Ko ES, Lim Y, et al. Breast Cancer heterogeneity: MR imaging texture analysis and survival outcomes. Radiology. 2017;282(3):665\u201375. https:\/\/doi.org\/10.1148\/radiol.2016160261.","journal-title":"Radiology."},{"issue":"3","key":"6523_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/RLI.0000000000000222","volume":"51","author":"MD Pickles","year":"2016","unstructured":"Pickles MD, Lowry M, Gibbs P. Pretreatment prognostic value of dynamic contrast-enhanced magnetic resonance imaging vascular, texture, shape, and size parameters compared with traditional survival indicators obtained from locally advanced breast Cancer patients. Investig Radiol. 2016;51(3):177\u201385. https:\/\/doi.org\/10.1097\/RLI.0000000000000222.","journal-title":"Investig Radiol"},{"key":"6523_CR26","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/S0959-8049(18)30477-5","volume":"92","author":"C Flynn","year":"2018","unstructured":"Flynn C, Gullo G, Walshe J, et al. Use of contrast-enhanced magnetic resonance imaging (MRI) to predict pathological response after trastuzumab (T) - based neoadjuvant chemotherapy (NAC) for HER2-positive breast cancer (HER2BrCa). Eur J Cancer. 2018;92:S83. https:\/\/doi.org\/10.1016\/S0959-8049(18)30477-5.","journal-title":"Eur J Cancer"},{"issue":"6","key":"6523_CR27","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.2214\/ajr.184.6.01841774","volume":"184","author":"SC Partridge","year":"2005","unstructured":"Partridge SC, Gibbs JE, Lu Y, et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol. 2005;184(6):1774\u201381. https:\/\/doi.org\/10.2214\/ajr.184.6.01841774.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"6523_CR28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1148\/radiol.2017162823","volume":"285","author":"J Wu","year":"2017","unstructured":"Wu J, Li B, Sun X, et al. Heterogeneous enhancement patterns of tumor-adjacent parenchyma at MR imaging are associated with Dysregulated signaling pathways and poor survival in breast Cancer. Radiology. 2017;285(2):401\u201313. https:\/\/doi.org\/10.1148\/radiol.2017162823.","journal-title":"Radiology."},{"issue":"1","key":"6523_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1687-6180-2012-40","volume":"2012","author":"Y Wang","year":"2012","unstructured":"Wang Y, Che X, Ma S. Nonlinear filtering based on 3D wavelet transform for MRI denoising. EURASIP J Adv Signal Process. 2012;2012(1):40. https:\/\/doi.org\/10.1186\/1687-6180-2012-40.","journal-title":"EURASIP J Adv Signal Process"},{"issue":"1","key":"6523_CR30","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1117\/1.JMI.5.1.011008","volume":"5","author":"I Banerjee","year":"2018","unstructured":"Banerjee I, Malladi S, Lee D, et al. Assessing treatment response in triple-negative breast cancer from quantitative image analysis in perfusion magnetic resonance imaging. J Med imaging (Bellingham, Wash). 2018;5(1):11008. https:\/\/doi.org\/10.1117\/1.JMI.5.1.011008.","journal-title":"J Med imaging (Bellingham, Wash)"},{"issue":"4","key":"6523_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11548-012-0793-3","volume":"8","author":"RM Rangayyan","year":"2013","unstructured":"Rangayyan RM, Banik S, Chakraborty J, Mukhopadhyay S, Desautels JEL. Measures of divergence of oriented patterns for the detection of architectural distortion in prior mammograms. Int J Comput Assist Radiol Surg. 2013;8(4):527\u201345. https:\/\/doi.org\/10.1007\/s11548-012-0793-3.","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"6523_CR32","first-page":"606","volume-title":"Automated detection of architectural distortion using improved adaptive Gabor filter BT - breast imaging","author":"R Yoshikawa","year":"2014","unstructured":"Yoshikawa R, Teramoto A, Matsubara T, Fujita H. In: Fujita H, Hara T, Muramatsu C, editors. Automated detection of architectural distortion using improved adaptive Gabor filter BT - breast imaging. Cham: Springer International Publishing; 2014. p. 606\u201311."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6523-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-6523-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6523-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:05:53Z","timestamp":1612397153000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-6523-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,5]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6523"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-6523-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,5]]},"assertion":[{"value":"5 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.The Ethics Committee of the First Affiliated Hospital of Zhejiang Chinese Medical University has approved this retrospective study, in which informed consent was waived, but patient confidentiality was protected.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Wenli Cai: Shareholder of IQ Medical Imaging LLC.The other authors have no relevant conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}